(Press-News.org) People at high risk of HIV infection can reduce their risk of acquiring the disease by taking antiretroviral drugs, according to Cochrane researchers. In an update of a systematic review first published in 2009, the researchers found that uninfected people in relationships with HIV-infected partners, men who have sex with men and those in other high risk groups are at a lower risk of becoming infected with the virus if they regularly take drugs that are normally prescribed to treat people with HIV.
Antiretroviral therapy (ART) is the standard drug treatment for HIV in patients whose disease has progressed to a certain level. Antiretroviral drugs are also beginning to be used as prophylactics in people at high risk of acquiring the disease from sexual partners. The use of antiretroviral drugs in preventing as opposed to treating HIV infection is referred to as pre-exposure prophylaxis (PrEP). PrEP is often considered controversial, not only because uninfected people may develop resistance to the drugs and experience serious side effects such as kidney toxicity and bone density loss, but also because the idea that PrEP offers protection may encourage people to indulge in riskier sexual behaviour, thereby increasing their overall risk of HIV infection. It is therefore important to establish whether PrEP really works and what level of protection it affords.
The researchers analysed data from six trials that tested the protective effect of daily doses of the oral antiretroviral drug tenofovir disoproxil fumarate (TDF) with or without emtricitabine (FTC), compared to a placebo or intermittent use. In total, the trials involved 9,849 people, including men who have sex with men, partners of HIV-infected people, sex workers and people who have multiple sexual partners. Data from four of the trials and a total of 8,813 people showed that giving TDF plus FTC reduces the risk of HIV infection by around half, from 37 in 1,000 to 19 in 1,000. Data from two trials and a total of 4,027 people showed that TDF alone reduces the risk of HIV infection by nearly two thirds, from 26 in 1,000 to 10 in 1,000.
"Our findings suggest that antiretroviral drugs can reduce the risk of HIV infection for people in high risk groups," said lead researcher, Charles Okwundu of the Centre for Evidence-Based Health Care at Stellenbosch University in Tygerberg, South Africa. "However, in the search for highly reliable HIV prevention strategies, it is important to determine how pre-exposure prophylaxis can best be combined with existing programmes, as no strategy is likely to be 100 per cent effective."
Those taking antiretroviral drugs did not suffer more adverse effects in the trials, and sexual risk behaviour was similar in both the intervention and control groups. But the researchers say further research is required to ensure that PrEP, which is still a new approach, is safe and cost-effective. "There are still many questions that need to be answered," said Okwundu. "For example, how do we ensure that people adhere to their ART regimens? What are the long-term effects? Is pre-exposure prophylaxis cost-effective in the long run?"
### END
Drugs used to treat HIV also reduce risk of HIV infection
2012-07-11
ELSE PRESS RELEASES FROM THIS DATE:
Cyberwarfare, conservation and disease prevention could benefit from MU researcher's network model
2012-07-11
COLUMBIA, Mo. -- Computer networks are the battlefields in cyberwarfare, as exemplified by the United States' recent use of computer viruses to attack Iran's nuclear program. A computer model developed at the University of Missouri could help military strategists devise the most damaging cyber attacks as well as guard America's critical infrastructure. The model also could benefit other projects involving interconnected groups, such as restoring ecosystems, halting disease epidemics and stopping smugglers.
"Our model allows users to identify the best or worst possible ...
Potential cause of HIV-associated dementia revealed
2012-07-11
WASHINGTON — Researchers at Georgetown University Medical Center appear to have solved the mystery of why some patients infected with HIV, who are using antiretroviral therapy and show no signs of AIDS, develop serious depression as well as profound problems with memory, learning, and motor function. The finding might also provide a way to test people with HIV to determine their risk for developing dementia.
They say the answer, published in the July 11 issue of the Journal of Neuroscience, may ultimately lead to a therapeutic solution that helps these patients as well ...
Metamolecules that switch handedness at light-speed
2012-07-11
A multi-institutional team of researchers that included scientists with the U.S. Department of Energy's Lawrence Berkeley National Laboratory (Berkeley Lab) has created the first artificial molecules whose chirality can be rapidly switched from a right-handed to a left-handed orientation with a beam of light. This holds potentially huge possibilities for the application of terahertz technologies across a wide range of fields, including biomedical research, homeland security and ultrahigh-speed communications.
Chirality is the distinct left/right orientation or "handedness" ...
Not so happy: King penguins stressed by human presence
2012-07-11
King penguins tolerate some, but not all, human interference. Research published in BioMed Central's open access journal, BMC Ecology, investigates the adjustment of a king penguin colony on the protected Possession island in the subantarctic Crozet Archipelago to over 50 years of constant human disturbance.
A team of researchers from the University of Strasbourg, the Centre National de la Recherche Scientifique (CNRS) and the University of Lausanne, compared 15 king penguins (Aptenodytes patagonicus) breeding in areas disturbed daily by humans and 18 penguins breeding ...
Blood-brain barrier less permeable in newborns than adults after acute stroke
2012-07-11
The ability for substances to pass through the blood-brain barrier is increased after adult stroke, but not after neonatal stroke, according to a new study the UCSF that will be published July 11 in the Journal of Neuroscience.
The novel findings may have major implications for drug development and the treatment of neonatal stroke, the researchers said.
The blood-brain barrier is selectively permeable and blocks unwanted molecules from entering into the brain. The selectivity is achieved through fine coordination in function of many transporting systems in endothelial ...
Moderate drinking may reduce risk of rheumatoid arthritis
2012-07-11
Research: Long term alcohol intake and risk of rheumatoid arthritis in women: a population based cohort study
Moderate consumption of alcohol is associated with a reduced risk of developing rheumatoid arthritis, suggests a study published on bmj.com today.
The results show that women who regularly consume more than three alcoholic drinks a week for at least 10 years have about half the risk of developing rheumatoid arthritis compared with non-drinkers.
After adjusting for factors such as age, smoking and dietary habits, women who reported drinking more than three ...
Weight gain after quitting smoking higher than previously thought
2012-07-11
Research: Weight gain in smokers after quitting cigarettes: meta-analysis
Editorial: Quitting smoking and gaining weight: the odd couple
Giving up smoking is associated with an average weight gain of 4-5 kg after 12 months, most of which occurs within the first three months of quitting, finds a study published on bmj.com today.
Although this figure is higher than previously thought, an accompanying editorial argues that the health benefits of quitting far outweigh this modest gain in body weight and should not deter people from quitting.
It is well known that ...
Not all brand-consumer relationships are created equal, says University of Toronto study
2012-07-11
Toronto – Not all brand–consumer relationships are created equal.
Marketers who realize this will be in a better position to retain customers and improve the perceptions of consumers who are unhappy with a brand's service or product, says a new paper from the University of Toronto.
Consumers form connections with brands in ways that mirror social relationships.
How consumers evaluate a brand depends heavily on whether the brand adheres to—or violates—the implicit relationship agreement.
Pankaj Aggarwal, a marketing professor at the Rotman School of Management and ...
Preclinical development shows promise to treat hearing loss with Usher syndrome III
2012-07-11
A new study published in the July 11 issue of the Journal of Neuroscience details the development of the first mouse model engineered to carry the most common mutation in Usher syndrome III causative gene (Clarin-1) in North America. Further, the research team from Case Western Reserve University School of Medicine used this new model to understand why mutation in Clarin-1 leads to hearing loss.
Usher Syndrome is an incurable genetic disease and it is the most common cause of the dual sensory deficits of deafness and blindness. It affects an estimated 50,000 Americans ...
Researchers develop secure protocol for linking data registries for HPV surveillance
2012-07-11
Ottawa, ON – July 10, 2012 — Monitoring the effectiveness of the HPV vaccine in Canada requires that data from multiple registries and other data sources be combined. Linking registries can be problematic, however, since they are often managed by unrelated organizations. Privacy legislation may also restrict the sharing of data for such linkages. To address these challenges, Dr. Khaled El-Emam and his team at the CHEO Research Institute have developed a secure protocol that allows the linking of individual patient records without revealing personal information, which has ...